Evidence map›Paper›PMID 41616033›Full record

ArticlePLoS pathogens2026

Prevalence and mechanisms of high-level carbapenem antibiotic tolerance in clinical isolates of Klebsiella pneumoniae.

Trevor Cross, Facundo Torres, Nadia Nikulin, Abigail P McGee, Leena Jalees, Rhea Balakrishnan, Tolani Aliyu, Lars F Westblade, Abhyudai Singh, Tobias Dörr

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. A digital droplet microarray for measuring tolerance to antibiotics.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Infection and immunity · 2025
    Review
  8. Article
  9. Induced tolerance to UV stress drives survival heterogeneity in isogenicbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Trevor CrossDepartment of Microbiology, Cornell University, Ithaca, New York, United States of America.
Facundo TorresDepartment of Microbiology, Cornell University, Ithaca, New York, United States of America.
Nadia NikulinDepartment of Microbiology, Cornell University, Ithaca, New York, United States of America.
Abigail P McGeeWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Leena JaleesWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Rhea BalakrishnanWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Tolani AliyuWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Lars F WestbladeDepartments of Pathology and Laboratory Medicine, Medicine, and Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.
Abhyudai SinghDepartment of Electrical and Computer Engineering, University of Delaware, Newark, Delaware, United States of America.
Tobias DörrDepartment of Microbiology, Cornell University, Ithaca, New York, United States of America.ORCID https://orcid.org/0000-0003-3283-9161

Funding

IMMUNOBIOLOGY OF MYELOID AND LYMPHOID CELLST32AI007363 · NIAID · DARTMOUTH COLLEGE · PI Claudia V Jakubzick · 1990 to 2026
$9.5M
Cell envelope stress responses and the mechanism of antibiotic tolerance in Gram-negative pathogensR01AI143704 · NIAID · CORNELL UNIVERSITY · PI DOERR, TOBIAS · 2019 to 2023
$2.0M
The mechanism of autolysin regulation in Vibrio choleraeR01GM130971 · NIGMS · CORNELL UNIVERSITY · PI DOERR, TOBIAS · 2019 to 2025
$2.0M
Generalized fluctuation test for deciphering phenotypic switching within cell populationsR35GM148351 · NIGMS · UNIVERSITY OF DELAWARE · PI Abhyudai Singh · 2023 to 2026
$1.6M
NIAID NIH HHS R01 AI143704NIAID NIH HHS T32 AI007363NIGMS NIH HHS R01 GM130971NIGMS NIH HHS R35 GM148351
6 · The paper itself

Abstract

Antibiotic tolerance is the ability of bacteria to survive normally lethal doses of antibiotics for extended time periods. Clinically significant Enterobacterales, for example, can exhibit high tolerance to the last-resort antibiotic meropenem. Meropenem tolerance is associated with formation of cell wall-deficient spheroplasts that readily recover to rod shape and normal growth upon removal of the antibiotic. Both the true prevalence of tolerance, and genetic mechanisms underlying it, remain poorly understood. Here, we find that meropenem tolerance is widespread among clinical Enterobacterales. Using forward genetics, we uncover tolerance factors in a hypertolerant isolate of the ESKAPE pathogen Klebsiella pneumoniae. We find that multiple mechanisms contribute to tolerance, and that cell envelope stress responses (PhoPQ, CpxPRA, Rcs phosphorelay and OmpR/EnvZ) collectively promote spheroplast stability and recovery, while the lytic transglycosylase MltB counteracts it. Our data indicate that tolerance is widespread among clinical isolates, and that outer membrane maintenance is a key factor promoting survival of tolerant K. pneumoniae.

Indexed as

Anti-Bacterial AgentsCarbapenemsDrug Resistance, BacterialKlebsiella InfectionsKlebsiella pneumoniaeBacterial ProteinsHumansMeropenemMicrobial Sensitivity TestsThienamycinsAnti-Bacterial AgentsBacterial ProteinsCarbapenemsMeropenemThienamycins

Identifiers

PMID41616033
PMCPMC12880740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.